Summary African ancestry is associated with low vitamin D levels but high bone density. Fifty percent of African immigrants had low vitamin D levels, but <10 % had evidence of deficiency. The value of providing vitamin D supplementation to African immigrants without evidence of deficiency needs to be determined. 
Introduction
As degree of African ancestry increases, vitamin D levels decline and bone mineral density (BMD) increases [1] [2] [3] . Therefore, vitamin D requirements for the maintenance of bone health may differ by race and could be even lower in Africans than in African-Americans.
Clearly, determining vitamin D requirements is challenging. In fact, the Endocrine Society and the Institute of Medicine (IOM) disagree on the definition of vitamin D insufficiency. The Endocrine Society recommends a threshold of 25(OH)D <30 ng/mL (to convert to nmol/L multiply by 2.5), whereas the IOM supports a threshold of <20 ng/mL [4, 5] . However, these recommendations were based on studies in largely white cohorts and therefore may not be relevant to African descent populations. The challenge in making evidence-based recommendations for African descent populations is the paucity of data. For example, we reviewed the racial composition of 31 clinical investigations cited in the IOM report and found a combined total of 238,511 participants, 86 % white, only 7 % African descent, and 7 % other (Supplemental Table S1 ).
Furthermore, for African immigrants to the USA, no data exists on the relationship of 25(OH)D to BMD. The official position papers on vitamin D and health by the IOM, Endocrine Society, and the US Preventive Services Task Force (USPSTF) do not cite any references on African immigrants [4] [5] [6] . In fact, to our knowledge, there is only one publication on 25(OH)D levels in African immigrants in the USA. It is an assessment of 25(OH)D levels in 71 veiled Somali women living in Seattle, Washington [7] . Thus, there is no evidencebased data to guide evaluation of vitamin D status in African immigrants. Yet, this information is essential for informing policy and for providing optimal health care to one of the most rapidly growing immigrant populations in the USA. Since 1970, the African immigrant population in the USA has doubled every decade, growing to 1.6 million in 2012 and representing 4 % of the foreign born adults [8] .
In the evaluation of 25(OH)D status, the concentration of 25(OH)D at which parathyroid hormone (PTH) becomes suppressed, also called the inflection point, is used to define low 25(OH)D level [9, 10] . Biochemical deficiency is defined as the combination of low 25(OH)D levels and elevated PTH levels, whereas clinical deficiency is defined as the combination of low 25(OH)D levels and decreased BMD [4, 5, [9] [10] [11] .
Beyond 25(OH)D levels, bioavailable 25(OH)D is gaining attention as a marker of vitamin D sufficiency [12, 13] 
Materials and methods
The Africans in America cohort enrolls immigrants from subSaharan Africa, who are living in the metropolitan Washington, DC area (latitude 38°53′ N). As described previously, enrollees in the cohort are undergoing assessment of insulin resistance, beta-cell function, and glucose tolerance status [15] [16] [17] . In this report, we focus on the studies specifically performed to evaluate vitamin D status.
Of 197 African immigrants enrolled, 11 were excluded. Nine were taking vitamin D supplements, one person was found to have primary hyperparathyroidism, and one person reported having granulomatous disease. Therefore, vitamin D status was evaluated in 186 African immigrants (69 % male; age 38±10 (mean±SD), range 20-64 years; BMI 27.7±4.5, range 18.2-41.2 kg/m 2 ). The African region of origin of the participants was 54 % West, 21 % Central, and 25 % East (Supplemental Table S2 lists the countries in each region). None of the women wore veils. Recruitment was achieved by newspaper advertisements, flyers, and the NIH website. Participants self-identified as healthy. The absence of anemia, liver, renal, and thyroid disease was confirmed by routine laboratory tests. The study was approved by the NIDDK Institutional Review Board (ClinicalTrials.gov Identifier: NCT00484861). All participants gave written informed consent.
Analytic measures
25(OH)D was measured by the LiasonX chemiluminescence immunoassay, with an inter-assay coefficient of variation (CV) of 2.2 % (Diasorin, Stillwater, MN). VDBP was available in 181 consecutively enrolled participants and measured by commercial enzyme-linked immunosorbent monoclonal assay (R&D Systems, Minneapolis, MN). The inter-assay and intra-assay CV for VDBP measurement was 5.1-7.4 % and 5.7-6.2 %, respectively. Albumin and alkaline phosphatase were measured on the Roche Cobas 6000 Analyzer (Roche Diagnostics, Indianapolis, IN). Ionized calcium and intact PTH were available in 106 consecutively enrolled participants. Ionized calcium levels were measured by the ABL837 calcium ion-selective electrode instrument (Radiometer, Westlake, OH). Intact PTH was measured by electrochemiluminescence immunoassay on the Roche Cobas e601 analyzer with an inter-assay CV of 3.7 %.
Whole-body bone mineral density BMD was obtained from whole-body dual-energy X-ray absorptiometry (DXA) scans (Hologic Discovery, Bedford, MA) [18, 19] . T-scores present BMD relative to same sex individuals at peak bone mass, which is between age 20 and 29 years of age [20] . T-scores can be presented as sex-specific only or race-and sex-specific. For this study, white and AfricanAmerican sex-specific T-scores were calculated with NHAN ES 1999 -2004 as the reference population [21] . As recommended by the International Society for Clinical Densitometry (ISCD), white T-scores were used to determine fracture risk [20] . Therefore, osteopenia was defined as white T-scores between −1.0 and −2.5 and osteoporosis as white T-scores ≤−2.5. African-American T-scores were used to determine race-based differences in BMD.
Low 25(OH)D levels and deficiency

Low 25(OH)D was defined as the 25(OH)D concentration at which PTH became suppressed (i.e., the inflection point).
Biochemical 25(OH)D deficiency was defined as the combination of PTH >65 pg/mL and 25(OH)D below the inflection point.
Clinical 25(OH)D deficiency was defined as white T-scores ≤−1.0 and 25(OH)D below the inflection point.
Bioavailable 25(OH)D
Bioavailable 25(OH)D was calculated as described by Powe et al. [13] (Supplementary Methods). To determine the inflection point, the level of 25(OH)D at which PTH becomes suppressed, a two-part procedure was performed. First, locally weighted regression scatterplot smoothing (LOWESS) was performed with PTH versus 25(OH)D. LOWESS is a nonparametric method used to fit a smooth curve to data [22] . Second, multivariate adaptive regression splices (MARS) were used to identify the value of the inflection point detected by the smoothed data [23] .
Statistical analyses
Statistical analyses were performed with STATA v13 (College Station, TX). The Python open source package statsmodels (v. 0.6.1) was used for the LOWESS modeling with default parameters (statsmodels.api.nonparametric.lowess). The MATLAB open source package ARESLab (v. 1.5.1) was used for the MARS analysis. Results are presented as mean±SD unless stated otherwise. P≤0.05 was considered statistically significant.
Results
Population characteristics
Demographic and social characteristics including duration of stay in the USA did not differ by African region of origin (Table 1 ). In addition, 25(OH)D levels did not differ between immigrants from West and Central Africa or Central and East Africa. However, immigrants from West Africa had higher 25(OH)D levels than immigrants from East Africa (P=0.02, Table 1 ). Nonetheless, VDBP, albumin, calcium, alkaline phosphatase, PTH, and percent of immigrants with 25(OH)D <20 ng/mL did not differ by African region of origin. Therefore, the entire cohort was evaluated as a single group.
Vitamin D levels
Mean 25(OH)D levels for the cohort were 21±8, range 4-48 ng/mL (Table 1) . Eighty-three percent (155/186) of African immigrants had 25(OH)D <30 ng/mL and 46 % (85/186) had 25(OH)D <20 ng/mL (Table 1) .
Seasonal variation
All of the African immigrants lived in the Washington, DC area and the concentration of 25(OH)D did not vary by season (P=0.45) (Fig. 1 ). To ensure exposure to different seasons, the 9 % (17/186) of immigrants who had been in the USA for less than 2 years were excluded and the comparison by season repeated. The repeat analyses showed no seasonal variation in 25(OH)D levels (P=0.64). Therefore, no adjustments for season were performed.
Parathyroid hormone
Similar to the larger cohort, the 106 African immigrants who had PTH levels had a prevalence of 25(OH)D <30 and <20 ng/mL of 84 % (89/106) and 45 % (48/106), respectively. PTH levels were 44.8±16.2 pg/mL, range 20.2-101.8 pg/mL. A significant inverse correlation was observed between PTH and 25(OH)D (r = −0.31, P < 0.01) (Fig. 2a) . With LOWESS modeling (Fig. 2b) followed by MARS analyses (Fig. 2c) , it was determined that the inflection point, which is the 25(OH)D concentration at which PTH became suppressed, was 20 ng/mL.
Twelve of the 106 African immigrants had PTH >65 pg/ mL. The characteristics of these 12 immigrants are provided in Table 2 . Eight of the 12 African immigrants with elevated PTH levels had 25(OH)D <20 ng/mL. Therefore, the prevalence of biochemical 25(OH)D deficiency was 8 % (8/106). The 4 % (4/106) of immigrants with PTH >65 pg/mL and 25(OH)D ≥20 ng/mL were categorized as PTH-resistant.
Bone mineral density and vitamin D
No correlation was found between BMD and 25(OH)D (r=0.01, P=0.89) (Fig. 3) .
Assessment of BMD by white T-scores
Six percent (11/177) of African immigrants (eight men, three women, age range 31-63 years) had osteopenia with white Tscores between −1.0 and −2.2 (Fig. 3) . No African immigrants had white T-score ≤−2.5. Therefore, no one was classified as osteoporotic.
Of the 11 African immigrants with white T-scores ≤−1.0, only 5 immigrants had 25(OH)D concentrations <20 ng/mL. Therefore, clinical 25(OH)D deficiency occurred in 3 % (5/177) of African immigrants (Fig. 2) .
Supporting the horizontal relationship between BMD and 25(OH)D, the odds ratio for 25(OH)D occurring with white T- (Fig. 3) .
Assessment of BMD by African-American T-scores
Twenty-four percent (42/177) of African immigrants had African-American T-scores ≤−1.0. Specifically, 23 % (40/ 177) (29 men, 11 women, age range 20-64 years) had African-American T-scores between −1.0 and −2.5 and 1 % (2/177) (1 man, 1 woman, age range 42-48 years) had African-American T-scores ≤−2.5 (Supplemental Fig. S1 ). Using 25(OH)D <20 ng/mL and African-American Tscores, the odds ratio for low vitamin D being associated with decreased BMD was 1.03, 95 % CI 0.52, 2.07, P=0.93. Fig. S2 ). There was a significant inverse correlation between PTH and bioavailable 25(OH)D (r=−0.22, P=0.03) (Supplemental Fig. S3a) . The concentration of bioavailable 25(OH)D at which PTH was suppressed was 11 ng/mL (Supplemental Fig. S3b, c) . In addition, there was no correlation with BMD (r=0.03, P=0.70) (Supplemental Fig. S4 ). 
Bioavailable 25(OH)D
Vitamin D levels
Similar to reports in African-Americans, we found that 83 % of African immigrants had 25(OH)D <30 ng/mL and 46 % had 25(OH)D levels <20 ng/mL [18, 24] . In comparison, the frequency of 25(OH)D <30 and <20 ng/mL is lower in whites, specifically 70 and 30 %, respectively [18, 24] .
Vitamin D thresholds and biochemical deficiency
In the 106 immigrants who had PTH levels, we identified the inflection point for 25(OH)D as 20 ng/mL. In other studies, 25(OH)D inflection points have been reported to range from less than 20 ng/mL to as high as 40 ng/mL [11, 25, 26] . In three studies specifically focused on African descent populations, we found reports of inflection points for 25 [27] . It is notable that these three investigations and our study of African immigrants enrolled men and women across a wide age range, yet each study found very similar inflection points for 25(OH)D.
Defining biochemical deficiency as PTH 65 pg/mL and 25(OH)D <20 ng/mL, 11 % (12/106) had elevated PTH but only 8 % (8/106) had biochemical deficiency (i.e., PTH >65 pg/mL and 25(OH)D <20 ng/mL) ( Table 2 ). For the 4 % (4/106) of immigrants with PTH >65 pg/mL levels and 25(OH)D ≥20 ng/mL, PTH resistance must be considered. PTH resistance is decreased skeletal sensitivity to the bone resorptive effects of PTH and has been invoked to explain both denser bones and decreased rate of osteoporotic fracture in African-Americans [28] .
Among the eight immigrants with biochemical deficiency, only two had evidence of abnormality. A 50-year-old man had slight hypocalcemia with an ionized calcium concentration of 1.11 mmol/L (normal 1.12 to 1.32). In addition, a 41-year-old man had both elevated alkaline phosphatase level of 107 U/L (normal 35-105) and decreased BMD with a white T-score of −1.2. Nonetheless, all individuals with evidence of biochemical deficiency should be provided with vitamin D supplementation.
Vitamin D thresholds and clinical deficiency
As reported in African-Americans [18] , no relationship (i.e., correlation) was observed between BMD and 25(OH)D in African immigrants. In contrast, in whites, low 25(OH)D strongly correlates with declining BMD and predicts increased fracture risk [18] . Therefore, in predominantly white populations, vitamin D supplementation is considered to be an important tool for primary prevention [4, 5] . In African-Americans, the paradoxical findings of low 25(OH)D levels, low fracture risk, and high BMD have led investigators from three key studies, the Women's Health Initiative, the National Osteoporosis Risk Assessment, and the Study of Osteoporotic Fractures, to suggest that the development of race-specific guidelines may be necessary [29] [30] [31] . The underlying assumption is that African-Americans may need less 25(OH)D to maintain bone health than whites. Our work with African immigrants provides support for this view in another population of African descent.
Overall, in our study, low BMD occurred across a wide range of 25(OH)D (9 to 35 ng/mL) (Fig. 2) . Furthermore, the odds ratio for 25(OH)D <20 ng/mL predicting T-score < −1.0 was not significant. Therefore, when low BMD does occur in African immigrants, reasons other than low vitamin D must also be considered. Nonetheless, for the 3 % (5/177) of African immigrants who met the classic definition of clinical deficiency, vitamin D supplementation would be wise.
Interestingly, 24 % of African immigrants had AfricanAmerican T-scores ≤−1.0, but only 6 % had white T-scores ≤−1.0 (P<0.001). The higher prevalence of low BMD using African-American rather than white T-scores suggests that relative to white controls, BMD is higher in African immigrants than whites.
There may be genetic reasons for why people of African descent appear to be relatively exempt from the adverse effects of low vitamin D levels on bone health. Studies of African-Americans have revealed that as degree of African ancestry increases, vitamin D levels decrease but bone density increases [1] [2] [3] . Bone structure may also be a factor. Nelson et al. has reported that African-American and Black South African women have thicker bone cortices and lower buckling ratio than white American and white South African women [32] . Furthermore, even at the same BMD, the Study of Osteoporotic Fractures has revealed that African-Americans are less likely to experience a fracture than whites [31] . Overall, in African descent populations, higher BMD and enhanced bone structure may mitigate the potential for adverse effects of low total 25(OH)D levels on bone health.
Seasonal variation
The Endocrine Society states that inadequate exposure to sunlight is a leading cause of low vitamin D levels [4] . Therefore, African descent populations with low vitamin D levels could potentially be treated with increased exposure to sunlight. However, cutaneous production of precursors to 25(OH)D represents a balance between exposure to sunlight and the melanin content of the skin; the former increases and the latter decreases cutaneous production of vitamin D precursors [33] .
Seasonal variation in 25(OH)D levels occurs in whites and African-Americans, but the variation is less in AfricanAmericans [34] [35] [36] . This race difference in degree of seasonal variation is usually attributed to the effect of melanin [37] . In African immigrants living in the Washington, DC metropolitan area (latitude 38°53′ N), we found that 25(OH)D did not vary by season (Fig. 1) . Presumably, African immigrants have less genetic admixture than African-Americans and a higher cutaneous melanin content. In the absence of seasonal variation in 25(OH)D, increased exposure to sunlight is not likely to be a viable therapeutic option for vitamin D insufficiency in African immigrants.
Bioavailable 25(OH)D
In studies comparing African-Americans and whites, it has been proposed that bioavailable 25(OH)D levels were more informative about vitamin D status than 25(OH)D [12, 13] . In our investigation in which only one race was studied and a monoclonal antibody for VDBP was used, the clinical insight provided by studying bioavailable 25(OH)D was equivalent to that obtained from 25 
Limitations
Limitations of this investigation include the cross-sectional design and the fact that PTH levels were available in only 106 of the 186 participants. However, for the identification of the 25(OH)D inflection point, our sample size is similar to other studies in which 25(OH)D levels were evaluated relative to PTH [25, 26] . Another challenge is that we used whole-body BMD instead of site-specific bone density. The advantage of whole-body BMD is that it provides a single composite measure of bone density, which has been shown in data from NHANES 1999-2004 to correlate well with subregions such as the lumbar spine [18, 19] . Another issue is the fact that this was a convenience sample. But, it is worth noting that recruitment for our study was facilitated by the fact that in the Washington, DC metropolitan area, African immigrants represent 15 % of the foreign-born population compared to 4 % in the USA overall [8] . Age is another consideration. In our study, mean age was 38±10, range 20-64 years. If the participants were older, it is possible that a higher percentage might have had a detectable decrease in BMD. However, a value of this study is that it is a report of 25(OH)D levels in African immigrants in the age range from 20 to 64 years. In addition, seasonal variation was assessed across the population rather than in the same individuals in different seasons. Finally, this study did not enroll children, adolescents, or lactating women and no veiled women requested to participate, so the results of this investigation cannot be extrapolated to these groups.
Conclusion
In this evaluation of African immigrants to America, we report that PTH became suppressed at 25(OH)D concentration of 20 ng/mL. Therefore, a threshold of <20 ng/mL appears to be an appropriate threshold to define low vitamin D in African immigrants. It is not clear, however, that a recommendation to provide vitamin D supplementation to all African immigrants with 25(OH)D <20 ng/mL should be made. Although~50 % of African immigrants had 25(OH)D <20 ng/mL, only 8 % had biochemical deficiency and 3 % had clinical deficiency. Definitely, vitamin D supplementation should be provided to the African immigrants with 25(OH)D <20 ng/mL and either elevated PTH or decreased BMD. The clinical conundrum is whether vitamin D supplementation should be offered to the large number of African immigrants with 25(OH)D <20 ng/ mL and no evidence of bone disease. To avoid unnecessary treatment and potential risks from raising vitamin D levels [30, 38, 39] , prospective studies are necessary to determine the need and safety of vitamin D supplementation in African immigrants to the USA.
